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Abstract 
The aim of the research: to optimize the treatment of patients with a disturbed cytokine profile by a bacterial lysate in an 
experimental model of periodontitis against the background of changes in the local and systemic immune response.
Materials and methods: prospective study has been conducted on experimental periodontitis in 42 rats for 90 days. The ani-
mals were treated by solution of «Respibron» and the reference drug «Imudon». The concentration of cytokines in the blood serum 
was determined by the enzyme immunoassay, circulating immune complexes – precipitation method is measured on a spectropho-
tometer, C-reactive protein – using a latex diagnosticum. All interventions and euthanasia of animals were carried out in compliance 
with the European principles. 
Results: the obtained data from the study indicate a high degree a state of decompensation of experimental periodontitis. 
An immuno-inflammatory reaction preceding periodontitis is accompanied by the disturbances of the cytokine balance, local and 
systemic immune response. Applying of bacterial lysates led to the compensation of bacterial dysbiosis, restoration of the balance of 
the activity of pro- and anti-inflammatory cytokines, and a decrease the hyperactivity of immunological markers.
Conclusion: the studies carried out have shown that the use of bacterial lysate is a pathogenetically substantiated component 
of therapeutic tactics. The normalizing effect of the lysate on the parameters of the immune response and cytokine profile has been 
reliably shown. Considering the immuno-inflammatory reaction at the experimental periodontitis, accompanied by the cytokine 
imbalance, study the pharmacological correction by bacterial lysate should continue from the point of view of establishing the me-
chanisms of development, protection, and restoration of tissues.
1. It has been proved that by the end of the 90-day period of observation of the course of experimental periodontitis, the power of 
natural compensatory mechanisms acquired a state of decompensation. It has manifested by increased pro-inflammatory cytokine IL-1β 
in 1.7 times, and TNF-α in 3 times, decreased anti-inflammatory cytokine IL-10 in 1.6 times; increased the concentration of CIC in the 
blood in 2 times, C-reactive protein in 4.4 times at the local level in the gum tissue homogenate of the control pathology group of animals.
2. The powerful corrective effect of bacterial lysates «Respibron» and «Imudon» on the indicators of the cytokine series on 
the model of chronic experimental periodontitis has been reliably established. The normalizing effect is due to the compensation of 
bacterial dysbiosis, restoration of the balance of the activity of pro- and anti-inflammatory cytokines, and a decrease in the hyper-
activity of immunological markers.
3. The therapeutic effect of «Respibron» (bacterial lysate of 13 strains of microorganisms) can be assessed as expressive and 
more powerful in comparison with «Imudon».
The obtained results make it possible to continue the study of the course of experimental periodontitis from the point of view 
of establishing the mechanisms of development, protection, and restoration of tissues under conditions of pharmacological correction 
with bacterial lysate «Respibron».









Generalized periodontitis occupies one of the leading places among the most common human 
diseases (WHO, 1990) and leads to tooth loss five times more often than caries and its complica-
tions [1, 2]. According to the latest latest epidemiological studies, the prevalence of dystrophic-in-
flammatory periodontal diseases in Ukraine among young people of working age ranges from 85 
to 100 %, which determines the social significance of this problem [3]. In this regard, the treatment 
of periodontal diseases remains one of the urgent medical and social problems in modern dentistry.
The development and progression of periodontitis is based on the mechanisms of imbalance 
between microflora and protective factors, regulated by immune mechanisms. As a result, auto-
immune reactions and inflammation are triggered, which leads to the destruction of the body’s 
own structures. Pro-inflammatory (IL-1β, IL-6, IL-8, TNF-α) and anti-inflammatory (IL-4, IL-10) 
cytokines are involved in the regulation of inflammatory processes [4, 5]. These substances belong 
to a group of regulatory peptides involved in all stages of the immune response. Cytokines exhibit 
universal biological effects to the action of various pathogenic factors. They are important regula-
tors of inflammation, intercellular interactions at the local and systemic levels. There are activation 
of lymphocytosis, phagocytosis, synthesis of interferons, stimulation of mitosis, and there are many 
reactions, which responsible for other processes associated with the inflammatory response [6, 7].
It has been proven that the dystrophic-inflammatory process in the periodontal tissues de-
velops both against the background of decreased immune responses of nonspecific and specific 
local immunity, in particular in the oral cavity, and against the background of insufficient immune 
protection at the level of the whole organism [8]. Therefore, one of the leading places in the treat-
ment of periodontal disease is immunocorrective therapy [9].
According to the literature, the chronic inflammatory process is caused by the damaging ef-
fect of the pathogen on the mucous membrane and the development of immunodeficiency due to the 
activation of free radical oxidation and an imbalance of pro-inflammatory and anti-inflammatory 
cytokines. This leads to cell apoptosis and cell alteration of various origins [10].
In connection with the above, the next stage of our work was to study the role of imbalance 
in the cytokine system in experimental periodontitis, which regulate intercellular interactions of 
all links of the immune system and intersystem interactions and the influence of «Respibron» on 
immune status experimental periodontitis. 
The aim of this article was the correction of a disturbed cytokine profile by a bacterial 
lysate in an experimental model of periodontitis against the background of changes in the local 
and systemic immune response on the basis of the Central Research Laboratory of the NUPh. The 
scientific novelty based on pathophysiological research of the peculiarities of the course of the 
disturbed cytokine profile on an experimental model of periodontitis and its pharmacological cor-
rection. The work was carried out in accordance with the research plan of the National University 
of Pharmacy («Technology of obtaining original and combined drugs in various forms», research 
work No. 0108U009174). The practical significance of carrying out a number of pathophysiological 
studies for medical practice lies in the theoretical generalization and new solution of the urgent 
scientific and practical problem of modern biological and medical pathological physiology – the 
role of the influence of bacterial lysates in the pathogenetic therapy of periodontitis, which makes 
it possible to pathogenetically substantiate the principles of correction of this pathological process.
2. Materials and methods
The studies were carried out at the Central Scientific Research Laboratory of the NUPh, 
which is certified by the State Pharmacological Center of the Ministry of Health of Ukraine (certi-
ficate No. 008/11 dated 18.10.2011). Experiments were carried out in the fall of 2020 on 48 outbred 
male rats weighing 180–190 g. Experimental periodontitis in rats was caused by keeping rats on 
a light consistency diet with a high carbohydrate content by O. I. Evdokimov modified by A. I. Suk-
mansky and A. Makarenko [11]. The animals were divided into 4 groups: 1st group – intact ani-
mals; 2nd group – rats with experimental periodontitis; 3rd – rats with experimental periodontitis, 
which were irrigated with an aqueous solution of «Respibron» at a dose of 10 mg/kg once a day; 
4th group – rats with experimental periodontitis, which were irrigated with an aqueous solution of 
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the reference drug. The duration of the experiment was 90 days: the simulation of periodontitis 
lasted 60 days (30 days were treated with «Respibron» (bacterial lysate) and the reference drug – 
a well-known agent with immunomodulatory properties «Imudon», which includes lysates of 
strains of the most common bacterial pathogens of the pathological process in the cavity mouth) [9]. 
Its mechanism of action is to stimulate the protective reactions of the oral mucosa by increasing 
the phagocytic activity of polymorphonuclear leukocytes (PML), the content of lysozyme in mixed 
saliva, stimulation of immunocompetent cells, as well as stimulation and increase of secretory IgA.
Determination of the level of cytokines in the blood serum was carried out by the enzyme 
immunoassay [12] on the analyzer «Multiscane Biotech» using test systems manufactured by 
«Caltag laboratories» (USA). Obtaining blood serum for determining biochemical parameters: 
animals were decapitated under inhalation anesthesia, blood was collected in silicone tubes. Blood 
serum was obtained by conventional methods. The samples were incubated in a thermostat at 37 °С 
for 20 minutes, centrifuged at 3000 rpm for 15 minutes.
Circulating immune complexes: precipitation method with 3.5 % polyethylene glycol solu-
tion PEG test OP280. A solution of polyethylene glycol (PEG) is capable of precipitating aggre-
gated immune globulins and immune complexes from serum. The change in the density of the 
solution is recorded on a spectrophotometer at a wavelength of 250 nm. Different concentrations of 
PEG (2.5; 3.5; 7 and even 10 %) cause precipitation of immune complexes of different molecular 
weights and sizes. Low concentrations of PEG precipitate large complexes, while high concentra-
tions cause precipitation of low molecular weight compounds. 3.5 % PEG flocculates the most com-
mon «intermediate» complexes of medium size. The level of circulating immune complexes (CIC) is 
measured on a spectrophotometer at 280 nm and is expressed in units of optical density [13].
C-reactive protein (CRP) was determined using a latex diagnosticum (CRP – latex test, 
NPL Granum LLC, Ukraine). The principle of the method is based on the detection in human blood 
serum of an acute phase protein – C-reactive protein, which enters into an agglutination reaction 
with antibodies against C-reactive protein adsorbed on neutral latex particles. C-reactive protein 
was quantified [13]. 
Evaluation of the results of biochemical studies was carried out in accordance with existing 
standards by comparing the indicators of the comparison group with the main and initial indica-
tors, as well as between the subgroups of the comparison group, depending on the exposure of the 
experiment [13].
All interventions and euthanasia of animals were carried out in compliance with the prin-
ciples of the «European Convention for the Protection of Vertebrate Animals used for Experimental 
and Other Scientific Purposes» (Strasbourg, 1986, as amended in 1998) and the resolution of the 
Fifth National Congress on Bioethics (Kyiv, 2013).
The NUPh Bioethics Commission did not find any violations of moral and ethical standards 
during research work (protocol No. 1 dated 02/05/2020).
The animals were taken out of the experiment by decapitation under light inhalation anes-
thesia (desiccator). 
Statistical analysis of the data was carried out to determine the arithmetic mean (X) and its 
statistical error (Sx) for groups with a normal distribution of characteristics, and the median (Me) 
and minimum and maximum dates for groups with an abnormal distribution of characteristics. 
To analyze the differences, the Newman-Keisley test and the Dunnett test were used. Evaluation 
of «0» hypotheses was carried out at a significance level of no more than 0.05 [13].
3. Research results
On the 60th day of the experiment, the concentration of IL-1β was 1.5 times higher than the 
value in the intact control group, and tumor necrotic factor (TNF-α) – 2.6 times. However, the con-
tent of anti-inflammatory IL-10 remained almost at the level of intact control (Table 1). Thus, the 
concentration of pro-inflammatory cytokines significantly increases in experimental periodontitis.
On the 90th day of the experiment, the concentration of IL-1β increased 1.7 times, and 
TNF-α – 3 times. Along with this, the concentration of the anti-inflammatory cytokine IL-10 sig-
nificantly decreased by 1.6 times.
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The influence of «Respibron» on the dynamics of the level of cytokines in the blood of rats with experimental 
periodontitis in comparison with «Imudon», (М ± m; n = 8)
Animal groups IL-1β, pg/ml TNF-α, pg/ml IL-10, pg/ml
60 days of experiment
Intact control 37.53 ± 1.68 42.56 ± 3.50 49.67 ± 3.55
Control pathology (periodontitis) 58.38 ± 6.36* 105.15 ± 6.8* 38.00 ± 3.58
«Respibron» + periodontitis 55.56 ± 3.58* 128.99 ± 9.42* 39.75 ± 2.61
«Imudon» + periodontitis 57.25 ± 4.32* 133.93 ± 8.39* 37.32 ± 3.84
90 days of experiment
Intact control 38.59 ± 2.61 44.33 ± 4.17 47.01 ± 2.78
Control pathology (periodontitis) 64.56 ± 1.71* 138.30 ± 13.84* 28.72 ± 2.13*
«Respibron» + periodontitis 42.48 ± 1.97** 64.27 ± 9.39** 45.75 ± 4.54**
«Imudon»+ periodontitis 48.06 ± 2.46** 77.66 ± 8.58*/** 41.58 ± 2.55
Note: * – the differences are statistically significant to the indices of intact control, p < 0.05; ** – the differences are statisti-
cally significant to the indicators of control pathology, p < 0.05; # – differences are statistically significant to the indicators of 
the «Imudon» group, p < 0.05; n – the number of animals in the group
Interleukin 1β (IL-1β) is a key pleiotropic pro-inflammatory cytokine that plays a funda-
mental role in the development of inflammation [3, 4]. Its functions are to initiate and regulate 
inflammatory processes, stimulate the synthesis of acute phase proteins and other cytokines (IL-2, 
IL-3, IL-6, TNF). IL-1 is able to produce by some cells tumor necrosis factor-α (TNF-α) [6, 14]. 
Thus, the presented results indicate that dysregulation of the production of various forms of cyto-
kines is observed in animals with experimental periodontitis. 
Applying of «Respibron» for experimental periodontitis in rats, the concentration of IL-1β 
and TNF-α statistically significantly decreased in comparison with the indicators of animals from 
the control pathology group by 1.5 and 2.2 times, respectively (p < 0.05) and was equal to intact 
control (Table 1).
Against the background of the comparison «Imudon», a restoration of the balance of pro-in-
flammatory and anti-inflammatory cytokines was also observed, but to a lesser extent than with 
the use of «Respibron». Thus, the content of IL-1β decreased to the level of intact animals, however, 
the concentration of TNF-α and IL-10, although it decreased in the control pathology, did not reach 
the values of the physiological norm (Table 1). All of these changes were statistically significant. 
Interleukin 10 (IL-10) is one of the main anti-inflammatory cytokines. Like IL-1β, it ex-
hibits multiple pleiotropic effects in the regulation of immune processes and inflammation. As 
our studies have shown, the content of IL-10 in chronic periodontitis in the blood of animals with 
control pathology increases 1.8 times compared with intact values. Applying of «Respibron» for 
experimental periodontitis in rats, the concentration of IL-10 statistically significantly decreased 
in comparison with the indicators of animals from the control pathology group and was equal 
to intact control.
As our studies have shown, the content of CIC in chronic periodontitis in the blood of ani-
mals with control pathology increases 1.8 times compared with intact values. At day 90 of the ex-
periment, the concentration of CIC in the blood of rats from the control pathology group exceeded 
the value of intact animals by 2 times (Table 2). 
In our experiment, the level of C-reactive protein increased 7.2 times at 60 days, and re-
mained elevated 4.4 times at 90 days of observation compared with intact animals. Some reduction 
of this indicator on 90 days of experience testifies to spontaneous convalescence of inflammatory 
process at rats from group of control pathology.
When using «Respibron», the CIC content decreased to the level of intact values. A signifi-
cant decrease in the content of CRP was also observed, however, a complete normalization of this 
indicator did not occur with the use of the test agent (Table 2).
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The effect of «Respibron» on the dynamics of CIC and CRP in the serum of rats with experimental 
periodontitis in comparison with «Imudon» (М ± m; n = 8)
Animal groups CIC, 3.5 % CRP, g/l
60 days of experiment
Intact control 0.17 ± 0.01 5 (4; 6)
Control pathology (periodontitis) 0.31 ± 0.03 36 (24; 48)*
«Respibron» + periodontitis 0.30 ± 0.02 36 (24; 42)*
«Imudon» + periodontitis 0.31 ± 0.03 30 (24; 48)*
90 days of experiment
Intact control 0.18 ± 0.01 5.5 (4; 6)
Control pathology (periodontitis) 0.38 ± 0.02* 24 (24; 36)*
«Respibron» + periodontitis 0.23 ± 0.03** 6 (10; 12)*/**
«Imudon»+ periodontitis 0.28 ± 0.03*/** 12 (12; 24)*/**
Note: * – the differences are statistically significant to the indices of intact control, p < 0.05; ** – the differences are statisti-
cally significant to the indicators of control pathology, p < 0.05; # – differences are statistically significant to the indicators of 
the «Imudon» group, p < 0.05; n – the number of animals in the group
The dynamics of the CIC and CRP against the background of the use of the reference 
drug «Imudon» was similar to that observed with the introduction of «Respibron», but to a some-
what lesser extent – the concentrations of both CIC and CRP decreased relative to the values 
in the control pathology group, but remained elevated relative to the values in the intact control 
group (Table 2). These changes were statistically significant.
4. Discussion
In recent decades, a number of studies have been published that characterize the develop-
ment of experimental periodontitis from the viewpoint of immunological disorders [15]. Deserves 
special attention the idea of [6, 16] bacterial contamination as a factor of the development of experi-
mental periodontitis, which was proposed in 2015 [14]. There is proposed the concept of an increase 
in the role of bacterial contamination in patients with periodontitis against the background of a de-
crease in the expression of antimicrobial peptides in the epithelium of oral cavity, which can further 
lead to invasion of initiation of chronic systemic inflammation [17, 18]. Our study of the spectrum 
of cytokines showed that the concentration of pro-inflammatory cytokines significantly increases 
at the 60th and 90th day of the experiment (concentration of IL-1β and TNF-α and anti-inflam-
matory IL-10 significantly decreased. The obtained dynamics of changes in the studied cytokines 
correlates with the data of other researchers and indicates the development of an imbalance in the 
ratio of pro-inflammatory/anti-inflammatory cytokines in experimental periodontitis [19].
Interleukin 1β (IL-1β) is a key pleiotropic pro-inflammatory cytokine that plays a funda-
mental role in the development of inflammation [20]. Its functions are to initiate and regulate in-
flammatory processes, activate neutrophils, T- and B-lymphocytes, stimulate the synthesis of acute 
phase proteins and other cytokines (IL-2, IL-3, IL-6, TNF). It is IL-1β that induces the synthesis 
of low molecular weight mediators of inflammation (nitric oxide and prostaglandins), chemokines 
that attract neutrophils to the inflammation zone, trigger the expression of adhesion molecules on 
leukocytes and endothelial cells [21].
It has been shown that IL-1β is of the greatest importance in the development of the prima-
ry immune response to infection with periodontal pathogenic microbiota – in this pathology, its 
concentration in the gingival and oral fluids increases already in the early stages of inflammation. 
Borzikova N. S. (2015) proved that the concentration of IL-1β in the oral fluid has a positive cor-
relation with the depth of the periodontal pocket. Interleukin-1β promotes the generalization of the 
inflammatory process in the periodontium [6, 14].
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IL-1 is able to enhance its production by some cells, which contributes to the rapid growth of 
its level. It has been shown that in response to not only a microbial agent, but also under the influ-
ence of other cytokines, many non-immune cells (keratinocytes, fibroblasts) can also increase the 
production of IL-1β and tumor necrosis factor-α (TNF-α) [8]. At the earliest stages of the develop-
ment of inflammation, IL-1 and TNF-α stimulate the migration of leukocytes to the inflammation 
focus. Their secondary effect is manifested as a result of the induction of the synthesis of pro-in-
flammatory cytokines - for example, IL-6, which potentiates the inflammatory response [20].
It has been shown that in periodontitis, one of the cytokine-dependent mechanisms of the 
destruction of the extracellular matrix is the overproduction of TNF-α, which is induced by mi-
crobial agents due to the activation of matrix metalloproteases [22]. All of these cytokines activate 
the synthesis of eicosanoids, matrix metalloproteinases (MMPs), and reactive oxygen species in 
tissues [5]. The immune response to infection leads to destruction of the tissues of the oral cavity 
and, as a result, to the systemic distribution of lipopolysaccharides (LPS), which in patients with 
hyperreactivity maintains the inflammatory response for a long time. In this case, systemically ac-
tivated immune cells are attracted to the focus of inflammation. In the works [4, 20], a correlation 
was established between the level of pro-inflammatory cytokines in the gingival fluid with the 
concentration of microbial LPS in the blood plasma and clinical manifestations of periodontitis.
Thus, the presented results indicate that dysregulation of the production of various forms 
of cytokines is observed in animals with experimental periodontitis. An imbalance in the ratio of 
pro-inflammatory and anti-inflammatory factors determines the destructive nature of inflamma-
tion and its severity.
Applying of «Respibron» for experimental periodontitis in rats, the concentration of IL-1β 
and TNF-α statistically significantly decreased in comparison with the indicators of animals from 
the control pathology group. Against the background of the comparison «Imudon», a restoration 
of the balance of pro-inflammatory and anti-inflammatory cytokines was also observed, but to 
a lesser extent than with the use of «Respibron». 
Interleukin 10 (IL-10) is one of the main anti-inflammatory cytokines. Like IL-1β, it ex-
hibits multiple pleiotropic effects in the regulation of immune processes and inflam mation. 
Under the influence of IL-10, the expression of cytokines, T-helper-1 lymphocytes (Th1), 
MHC class II antigens and co-stimulating molecules on macrophages decreases, the induction of 
the secretion of inflammatory cytokines TNF-α and IL-1β is suppressed, the production of anti-
bodies is activated [14].
An imbalance of pro / anti-inflammatory cytokines in the blood of animals from the group 
of control pathology towards an increase in proinflammatory pathology indicates the development 
of not only local inflammation, but also the generalization of the inflammatory process, which is 
confirmed by the formation of an average mass Circulating Immune Complexes (CIC) – markers 
of the development of autoimmune processes in response to the formation of toxic products of en-
dothelial decay and periodontal tissues [6].
As our studies have shown, the content of CEC in chronic periodontitis in the blood of 
animals with control pathology increases much more compared with intact values. Normally, 
CECs are removed from the body by cellular, biochemical and enzymatic mechanisms by a system 
of mononuclear and tissue phagocytes, which are activated in the classical way by the complement 
system. Under normal conditions, excess CEC is effectively removed by phagocytosis, resulting 
in high concentrations of CEC do not lead to their pathologically significant accumulation. How-
ever, when the phagocytic activity of macrophages decreases, CECs are difficult to eliminate from 
the body [7]. One of the significant factors important for the manifestation of CEC pathogenicity 
is their size. The greatest pathological effects are exerted by CECs of medium size, formed with 
a small excess of antigen, capable of activating complement in an alternative way, which helps to 
maintain the inflammatory process [18]. At day 90 of our experiment, the concentration of CIC in 
the blood of rats from the control pathology group exceeded the value of intact animals.
C-reactive protein (CRP) is found in serum in various inflammatory and necrotic proces-
ses and reflects the intensity of the inflammatory process. By binding to T lymphocytes, it af-
fects their functional activity, initiating reactions of precipitation, agglutination, phagocytosis and 
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complement fixation. In our experiment, the level of C-reactive protein increased in 4.4 times at 
90 days of observation compared with intact animals. Some reduction of this indicator on 90 days 
of experience testifies to spontaneous convalescence of inflammatory process at rats from group of 
control pathology. Applying of «Respibron», the CIC content decreased to the level of intact values. 
The dynamics of the CIC and CRP against the background of the use of the reference drug «Imudon» 
was similar to that observed with the introduction of «Respibron», but to a somewhat lesser ex-
tent – the concentrations of both CIC and CRP decreased relative to the values in the control pa-
thology group, but remained elevated relative to the values in the intact control group.
Study limitations. The study of deep relationships of microbial associations, local immune 
mechanisms, analysis of the potential effects of anti-inflammatory therapy with bacterial lysates 
can be obtained in an experiment on animals, which is possible in future studies.
A prospective study of the cytokine mechanisms of the course of chronic periodontitis of 
the oral cavity against the background of changes in the parameters of immune relationships will 
make it possible to find ways of rational therapeutic tactics on the example of the action of the 
natural microbiota of preparations of bacterial lysates. This will allow analysis of the potential 
effects of such anti-inflammatory therapy in future studies.
5. Conclusion
1. It has been proved that by the end of the 90-day period of observation of the course 
of experimental periodontitis, the power of natural compensatory mechanisms acquired a state 
of decompensation. It has manifested by increased pro-inflammatory cytokine IL-1β in 1.7 times, 
and TNF-α in 3 times, decreased anti-inflammatory cytokine IL-10 in 1.6 times; increased the 
concentration of CIC in the blood in 2 times, C-reactive protein in 4.4 times at the local level in the 
gum tissue homogenate of the control pathology group of animals.
2. The powerful corrective effect of bacterial lysates «Respibron» and «Imudon» on the in-
dicators of the cytokine series on the model of chronic experimental periodontitis has been reliably 
established. The normalizing effect is due to the compensation of bacterial dysbiosis, restoration of 
the balance of the activity of pro- and anti-inflammatory cytokines, and a decrease in the hyperac-
tivity of immunological markers.
3. The therapeutic effect of «Respibron» (bacterial lysate of 13 strains of microorganisms) 
can be assessed as expressive and more powerful in comparison with «Imudon».
The results obtained make it possible to continue the study of the course of experimen-
tal periodontitis from the point of view of establishing the mechanisms of development, protec-
tion, and restoration of tissues under conditions of pharmacological correction with bacterial 
lysate «Respibron».
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